What was the overall market valuation of the antibodies market in 2024?

The overall market valuation was $15.23 Billion in 2024. Read More

What is the projected market valuation for the antibodies market by 2035?

The projected valuation for 2035 is $63.14 Billion. Read More

What is the expected CAGR for the antibodies market during the forecast period 2025 - 2035?

The expected CAGR for the antibodies market during the forecast period 2025 - 2035 is 13.8%. Read More

Which application segment had the highest valuation in 2024?

The Infectious Diseases application segment had the highest valuation at $5.0 Billion in 2024. Read More

What is the projected valuation for the Oncology application segment by 2035?

The projected valuation for the Oncology application segment by 2035 is $14.0 Billion. Read More

Which type of antibodies is expected to dominate the market by 2035?

Monoclonal Antibodies is expected to dominate the market with a projected valuation of $25.25 Billion by 2035. Read More

What was the valuation of the Research Institutes end-use segment in 2024?

The Research Institutes end-use segment was valued at $6.23 Billion in 2024. Read More

What is the projected valuation for the Intravenous mode of administration by 2035?

The projected valuation for the Intravenous mode of administration by 2035 is $38.56 Billion. Read More

Which key player had a presence in the antibodies market as of 2024?

Key players in the antibodies market include AbbVie, Roche, and Johnson & Johnson. Read More

What is the expected growth trend for the antibodies market in South America?

The antibodies market in South America is expected to grow significantly, with a projected valuation increase to $63.14 Billion by 2035. Read More

South America Antibodies Market

South America Antibodies Market Research Report By Type (Monoclonal Antibodies, Polyclonal Antibodies, Intravenous Immunoglobulin), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Neurology), By End Use (Hospitals, Diagnostic Laboratories, Research Institutes), By Mode of Administration (Subcutaneous, Intravenous, Intramuscular) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

13.8%

2024 Market Size

$ 15.23 Billion

2035 Market Size

$ 63.14 Billion

Medical Device ● Updated February 2026 Report ID: MRFR/MED/50200-HCR | Pages: 200 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Application (USD Billion)
  1. 4.1.1 Oncology
  2. 4.1.2 Autoimmune Diseases
  3. 4.1.3 Infectious Diseases
  4. 4.1.4 Neurology
2. 4.2 Construction, BY Type (USD Billion)
  1. 4.2.1 Monoclonal Antibodies
  2. 4.2.2 Polyclonal Antibodies
  3. 4.2.3 Intravenous Immunoglobulin
3. 4.3 Construction, BY End Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutes
4. 4.4 Construction, BY Mode of Administration (USD Billion)
  1. 4.4.1 Subcutaneous
  2. 4.4.2 Intravenous
  3. 4.4.3 Intramuscular
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AbbVie (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck & Co. (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Amgen (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bristol-Myers Squibb (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Novartis (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GSK (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Sanofi (FR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY END USE
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY MODE OF ADMINISTRATION
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 CONSTRUCTION, BY END USE, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY END USE, 2024 TO 2035 (USD Billion)
18. 6.18 CONSTRUCTION, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY MODE OF ADMINISTRATION, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America South America Antibodies Market Segmentation

South America Antibodies Market By Application (USD Billion, 2025-2035)

Oncology
Autoimmune Diseases
Infectious Diseases
Neurology

South America Antibodies Market By Type (USD Billion, 2025-2035)

Monoclonal Antibodies
Polyclonal Antibodies
Intravenous Immunoglobulin

South America Antibodies Market By End Use (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes

South America Antibodies Market By Mode of Administration (USD Billion, 2025-2035)

Subcutaneous
Intravenous
Intramuscular

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”